tradingkey.logo

Sonoma Pharmaceuticals Inc

SNOA
查看详细走势图
3.630USD
+0.050+1.40%
收盘 12/24, 13:00美东报价延迟15分钟
5.99M总市值
亏损市盈率 TTM

Sonoma Pharmaceuticals Inc

3.630
+0.050+1.40%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+1.40%

5天

+2.25%

1月

+13.08%

6月

+24.74%

今年开始到现在

+34.94%

1年

+32.97%

查看详细走势图

TradingKey Sonoma Pharmaceuticals Inc股票评分

单位: USD 更新时间: 2025-12-24

操作建议

Sonoma Pharmaceuticals Inc当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在药品行业排名73/158位。机构持股占比非常高,近一月多位分析师给出公司评级为强力买入。最高目标价14.80。中期看,股价处于平稳状态。近一个月,市场表现较强,基本面评分较高,但较强的走势得没有得到技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

Sonoma Pharmaceuticals Inc评分

相关信息

行业排名
73 / 158
全市场排名
181 / 4562
所属行业
药品

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 1 位分析师
强力买入
评级
14.800
目标均价
+322.25%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Sonoma Pharmaceuticals Inc亮点

亮点风险
Sonoma Pharmaceuticals, Inc. is a global healthcare company. The Company is engaged in developing and producing stabilized hypochlorous acid (HOCl) products for a range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Its products are all classified as medical devices and categorized as prescription, over-the-counter (OTC) and office dispense products. It offers both prescription and OTC dermatology products, including Epicyn Facial Cleanser, Levicyn Dermal Spray, Levicyn Gel, Levicyn Spray Gel, Celacyn Scar Management Gel. In the United States, it offers Microcyn wound and skin care both as an OTC and prescription product. Its eyecare products include Acuiycn Eyelid and Eyelash Hygiene, and Ocucyn Eyelid and Eyelash Cleanser. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a wide spectrum of animal wounds and infections.
业绩增长期
公司处于发展阶段,最新年度总收入14.29M美元
估值低估
公司最新PE估值-1.81,处于3年历史低位
机构加仓
最新机构持股106.22K股,环比增加19.12%
先锋集团持仓
明星投资者先锋集团持仓,最新持仓市值20.87K
活跃度增加
近期活跃度增加,过去20天平均换手率-0.01

Sonoma Pharmaceuticals Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Sonoma Pharmaceuticals Inc简介

Sonoma Pharmaceuticals, Inc. is a global healthcare company. The Company is engaged in developing and producing stabilized hypochlorous acid (HOCl) products for a range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Its products are all classified as medical devices and categorized as prescription, over-the-counter (OTC) and office dispense products. It offers both prescription and OTC dermatology products, including Epicyn Facial Cleanser, Levicyn Dermal Spray, Levicyn Gel, Levicyn Spray Gel, Celacyn Scar Management Gel. In the United States, it offers Microcyn wound and skin care both as an OTC and prescription product. Its eyecare products include Acuiycn Eyelid and Eyelash Hygiene, and Ocucyn Eyelid and Eyelash Cleanser. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a wide spectrum of animal wounds and infections.
公司代码SNOA
公司Sonoma Pharmaceuticals Inc
CEOTrombly (Amy)
网址https://sonomapharma.com/

常见问题

Sonoma Pharmaceuticals Inc(SNOA)的当前股价是多少?

Sonoma Pharmaceuticals Inc(SNOA)的当前股价是 3.630。

Sonoma Pharmaceuticals Inc的股票代码是什么?

Sonoma Pharmaceuticals Inc的股票代码是SNOA。

Sonoma Pharmaceuticals Inc股票的52周最高点是多少?

Sonoma Pharmaceuticals Inc股票的52周最高点是6.920。

Sonoma Pharmaceuticals Inc股票的52周最低点是多少?

Sonoma Pharmaceuticals Inc股票的52周最低点是1.750。

Sonoma Pharmaceuticals Inc的市值是多少?

Sonoma Pharmaceuticals Inc的市值是5.99M。

Sonoma Pharmaceuticals Inc的净利润是多少?

Sonoma Pharmaceuticals Inc的净利润为-3.46M。

现在Sonoma Pharmaceuticals Inc(SNOA)的股票是买入、持有还是卖出?

根据分析师评级,Sonoma Pharmaceuticals Inc(SNOA)的总体评级为--,目标价格为14.800。

Sonoma Pharmaceuticals Inc(SNOA)股票的每股收益(EPS TTM)是多少

Sonoma Pharmaceuticals Inc(SNOA)股票的每股收益(EPS TTM)是-2.007。
KeyAI